• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Enhanced radiation therapy using microRNA via regulation of ICAM2 signalling

Research Project

Project/Area Number 22659364
Research Category

Grant-in-Aid for Challenging Exploratory Research

Allocation TypeSingle-year Grants
Research Field Surgical dentistry
Research InstitutionChiba University

Principal Investigator

TANZAWA Hideki  千葉大学, 大学院・医学研究院, 教授 (50236775)

Co-Investigator(Kenkyū-buntansha) OGAWARA Katsunori  千葉大学, 医学部附属病院, 講師 (20372360)
Project Period (FY) 2010 – 2011
Project Status Completed (Fiscal Year 2011)
Budget Amount *help
¥3,190,000 (Direct Cost: ¥2,800,000、Indirect Cost: ¥390,000)
Fiscal Year 2011: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2010: ¥1,500,000 (Direct Cost: ¥1,500,000)
KeywordsmicroRNA / 口腔癌 / 放射線耐性 / ICAM遺伝子 / micro RNA
Research Abstract

We previously reported that intercellular adhesion molecule 2 (ICAM2) gene is closely associated with radioresistant mechanism in oral squamous cell carcinoma (OSCC). And we identifind miR-125b potentially regulating ICAM2 gene expression. In this study, we evaluated the potential of targeting miRNA-125b for overcoming radio-resistance of OSCC with controled ICAM2-associated signaling. Significantly downregulated expression of miR-125b was revealed in OSCC-derived cell lines and OSCC samples when compared with human normal keratinocytes. Furthermore, miR-125b-transfected cells showed an enhanced radiosensitivity to X-ray irradiation, and diminished ICAM2 mRNA expression.
The data suggest that upregulated expression of miR-125b can induce an enhanced radiosensitivity via regulation of ICAM2 signalling.

Report

(3 results)
  • 2011 Annual Research Report   Final Research Report ( PDF )
  • 2010 Annual Research Report

URL: 

Published: 2010-08-23   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi